Pear Therapeutics, Inc. (PEAR)


0.00 (0.00%)
Symbol PEAR
Price $0.0292
Beta 0.520
Volume Avg. 10.09M
Market Cap 4.089M
Shares () -
52 Week Range 0.009-6.74
1y Target Est -
DCF Unlevered PEAR DCF ->
DCF Levered PEAR LDCF ->
ROE 42.83% Strong Buy
ROA 26.05% Buy
Operating Margin -
Debt / Equity 122.96% Buy
P/E -0.08 Neutral
P/B 0.13 Neutral


Consensus EPS

Upgrades & Downgrades

Latest PEAR news

Mr. Christopher D. T. Guiffre J.D., M.B.A., MBA
Health Information Services
NASDAQ Capital Market

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.